OneMedNet Corporation (NASDAQ:ONMD) Short Interest Update

OneMedNet Corporation (NASDAQ:ONMD) was the recipient of a large growth in short interest in the month of July. As of July 31st, there was short interest totaling 1,816,220 shares, a growth of 425.7% from the July 15th total of 345,502 shares. Approximately 5.9% of the company’s shares are short sold. Based on an average trading volume of 3,840,358 shares, the short-interest ratio is currently 0.5 days.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Wall Street Zen downgraded shares of OneMedNet from a “hold” rating to a “sell” rating in a research note on Saturday, May 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of OneMedNet in a research note on Monday, June 1st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.

Insider Buying and Selling at OneMedNet

In related news, insider Jeffrey Yu acquired 172,414 shares of the business’s stock in a transaction dated Tuesday, June 16th. The shares were acquired at an average cost of $0.58 per share, for a total transaction of $100,000.12. Following the acquisition, the insider directly owned 8,621,680 shares in the company, valued at approximately $5,000,574.40. The trade was a 2.04% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Thomas Kosasa bought 1,449,275 shares of the firm’s stock in a transaction that occurred on Thursday, July 30th. The stock was bought at an average cost of $0.69 per share, for a total transaction of $999,999.75. Following the completion of the transaction, the director directly owned 18,538,150 shares of the company’s stock, valued at approximately $12,791,323.50. The trade was a 8.48% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased 2,300,238 shares of company stock valued at $1,601,664 over the last quarter. Insiders own 46.20% of the company’s stock.

Institutional Investors Weigh In On OneMedNet

Several institutional investors have recently bought and sold shares of ONMD. Virtu Financial LLC purchased a new position in shares of OneMedNet in the 4th quarter valued at $48,000. State Street Corp lifted its holdings in shares of OneMedNet by 41.5% during the 4th quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after acquiring an additional 34,200 shares in the last quarter. Jane Street Group LLC purchased a new stake in OneMedNet during the 4th quarter worth $119,000. HRT Financial LP purchased a new stake in OneMedNet during the 4th quarter worth $32,000. Finally, Exencial Wealth Advisors LLC increased its holdings in OneMedNet by 1.3% in the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after purchasing an additional 45,401 shares in the last quarter. 0.95% of the stock is currently owned by hedge funds and other institutional investors.

OneMedNet Trading Down 1.0%

NASDAQ:ONMD traded down $0.01 on Friday, hitting $0.77. 63,723 shares of the stock were exchanged, compared to its average volume of 2,178,660. The stock has a fifty day moving average of $0.66 and a 200-day moving average of $0.77. The stock has a market cap of $43.79 million, a PE ratio of -15.50 and a beta of 1.14. OneMedNet has a fifty-two week low of $0.49 and a fifty-two week high of $4.22.

OneMedNet (NASDAQ:ONMD) last released its quarterly earnings data on Friday, May 15th. The company reported ($0.04) earnings per share for the quarter. The firm had revenue of $0.10 million during the quarter.

OneMedNet Company Profile

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.